Vir Biotechnology
VIR
Vir Biotechnology (VIR) - Cash on Hand
Cash on Hand as of December 2023 : $1.52 B
According to Vir Biotechnology
's latest financial reports the company has $1.52 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vir Biotechnology - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.52 B | -36.62% |
| 2022-12-31 | $2.40 B | 239.2% |
| 2021-12-31 | $0.70 B | -3.9% |
| 2020-12-31 | $0.73 B | 92.17% |
| 2019-12-31 | $0.38 B | 289.5% |
| 2018-12-31 | $98.44 M | -47.61% |
| 2017-12-31 | $0.18 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -86.33% | 🇺🇸 USA |